CORONA Main Coronavirus thread

Krayola

Veteran Member
Just want to give a warning to the membership about Thailand Medical News. Some of the info they have is valuable but use discernment. I just read something there that was made up. I read what they posted and when I checked the source link where they supposedly got the info, they had made up stuff that was not in the research paper. If you read something over there, always check for the source and read the source before assuming it to be true.
 

TammyinWI

Talk is cheap
This is all SO evil and depraved. Praying against the evil daily, several times a day. May the cogs in the wheel, all of us :"useless eaters," in droves, go against the globalist cabal in this agenda, so it fails, from here on out!

I feel SO sorry for those that were deceived and took the jab(s).
 

Ractivist

Pride comes before the fall.....Pride month ended.
Flux....anti depressant....bad news. Any way to depress, suppress, or control the people.

Wake up world, look at the push, measure it against the actual reality here, not the propaganda....lots of folks are earning a ticket to paradise, for sure. Others are looking at the overall push, the data, the circumstantial evidence..... Fauci, the patents.....and on and on. Now labeling others, as Domestic terrorists...amazing the sheer audacity exhibited on a daily basis. Incredible....like a cop with a perp who has blood on his hands, the knife in his pocket, his name written in blood at the scene......nothing to see here. The worlds people are waking up.

Perhaps world war three will be all the worlds militaries and political class taking on all the worlds citizens. Our present state. Current weapons social media, political writs, bio weapons, bio shots, assassinations.........
 

Heliobas Disciple

TB Fanatic
Just want to give a warning to the membership about Thailand Medical News. Some of the info they have is valuable but use discernment. I just read something there that was made up. I read what they posted and when I checked the source link where they supposedly got the info, they had made up stuff that was not in the research paper. If you read something over there, always check for the source and read the source before assuming it to be true.

Thank you Krayola. That's really good info to have. Can you post the discrepency you found? If it's really egregious, I may stop posting articles from there. I agree, some of what they post is valuable, so it's going to be a weighing thing going forward. Maybe a disclaimer at the top of every post I bring over from there (?).

HD
 

Heliobas Disciple

TB Fanatic
(fair use applies) EMPHASIS MINE

Sources: US to recommend COVID vaccine boosters at 8 months
ZEKE MILLER
Mon, August 16, 2021, 10:54 PM

WASHINGTON (AP) — U.S. experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot, to ensure lasting protection against the coronavirus as the delta variant spreads across the country.

Federal health officials have been actively looking at whether extra shots for the vaccinated would be needed as early as this fall, reviewing case numbers in the U.S. as well as the situation in other countries such as Israel, where preliminary studies suggest the vaccine’s protection against serious illness dropped among those vaccinated in January.

An announcement on the U.S. booster recommendation was expected as soon as this week, according to two people familiar with the matter who spoke to The Associated Press on the condition of anonymity to discuss internal deliberations.

Doses would only begin to be administered widely once the Food and Drug Administration formally approves the vaccines. That action is expected for the Pfizer shot in the coming weeks.

Last week, U.S. health officials recommended boosters for some with weakened immune systems, citing their higher risk of catching the virus and evidence that the vaccines' effectiveness waned over time.

The director of the National Institutes of Health, Dr. Francis Collins, said Sunday the U.S. could decide in the next couple weeks whether to offer coronavirus booster shots to Americans this fall.

Among the first to receive them could be health care workers, nursing home residents and other older Americans, who were some of the first Americans to be vaccinated once the shots received emergency use authorization last December.

Since then, more than 198 million Americans have received at least one dose of a COVID-19 vaccine according to the Centers for Disease Control and Prevention, with more than 168 million fully vaccinated. Still, the country is experiencing a fourth surge of virus cases due to the more transmissible delta variant, which is spreading aggressively through unvaccinated communities but is also responsible for an increasing number of so-called “breakthrough infections” of fully vaccinated people.

Israel, which exclusively administered the Pfizer shot, has been offering a coronavirus booster to people over 60 who were already vaccinated more than five months ago in an effort to control its own surge in cases from the delta variant.

For months, officials had said data still indicated that people remain highly protected from COVID-19, including the delta variant, after receiving the two-dose Pfizer or Moderna regimen or the one-shot Johnson & Johnson vaccine. But U.S. health officials made clear Sunday they are preparing for the possibility that the time for boosters may come sooner than later.

“There is a concern that the vaccine may start to wane in its effectiveness,” Collins said. “And delta is a nasty one for us to try to deal with. The combination of those two means we may need boosters, maybe beginning first with health care providers, as well as people in nursing homes, and then gradually moving forward” with others, such as older Americans who were among the first to get vaccinations.

He said because the delta variant only started hitting the U.S. hard in July, the “next couple of weeks” of case data will help the U.S. make a decision.

Officials were continuing to collect information as well about the J&J vaccine, which was only approved in the U.S. in late February, to determine when to recommend boosters, one of the officials said.

The White House has said that even though the U.S. has begun sharing more than 110 million vaccine doses with the world, the nation has enough domestic supply to deliver boosters to Americans should they be recommended by health officials.

Global health officials, including the World Health Organization, have called on wealthier and more-vaccinated countries to hold off on booster shots to ensure the supply of first doses for people in the developing world.
 

Heliobas Disciple

TB Fanatic

Taliban ban COVID-19 vaccine in Eastern Afghanistan's Paktia province: Report
Wion Web Team
3 days ago

Afghanistan-based radio and television station Shamshad News has reported that the Taliban have banned the Covid vaccination in eastern Afghanistan's Paktia and posted a notice in this respect at Paktia Regional Hospital.

The COVID-19 vaccine ward has been closed for the last three days, according to province Public Health Director Walayat Khan Ahmadzai, and clients have been informed that the vaccine has been prohibited.

According to Ahmadzai, the Taliban urged the vaccination distribution team not to provide vaccines.

So yet, the armed Taliban have been silent on the subject.

Taliban Banned Using of COVID-19 Vaccines in Paktiahttps://t.co/x0O9qPbfUN pic.twitter.com/3G9TOlwzbk
— ShamshadNews (@Shamshadnetwork) August 12, 2021

When the Taliban gained control of the province, they allegedly removed Nishan Sahib from a Gurudwara.

Following an eight-day blitz into metropolitan centres by the Taliban, the Afghan government has virtually lost control of the majority of the nation, shocking Kabul's American supporters.

Meanwhile, after the provincial capital in the country's north was taken last week, a video on Facebook shows Taliban commanders celebrating their victory at the home of Afghan warlord Marshal Abdul Rashid Dostum in Sheberghan, Jowzjan.

Taliban commanders can be seen celebrating in a large hall owned by Dostum in the footage.

The attack began in early May after the US and its allies had almost completely withdrawn their soldiers from Afghanistan, with President Joe Biden aiming to bring the two-decade-long war to a close-by September 11.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Faster and cheaper COVID-19 testing using pencil lead
by Melissa Pappas, University of Pennsylvania
August 16, 2021

Testing is key to understanding and controlling the spread of COVID-19, which has already taken more than four million lives around the world. However, current tests are limited by the tradeoff between accuracy and the time it takes to analyze a sample.

engineers-create-faste.jpg

Credit: University of Pennsylvania

Another challenge of current COVID-19 tests is cost. Most tests are expensive to produce and require trained personnel to administer and analyze them. Testing in low-and middle-income communities has therefore been largely inaccessible, leaving individuals at greater risk of viral spread.

To address cost, time and accuracy, a new electrochemical test developed by Penn researchers uses electrodes made from graphite—the same material found in pencil lead. Developed by César de la Fuente, Presidential Assistant Professor in Bioengineering, Microbiology and Psychiatry with a secondary appointment in Chemical and Biomolecular Engineering, these electrodes reduce the cost to $1.50 per test and require only 6.5 minutes to deliver 100-pecent-accurate results from saliva samples and up to 88 percent accuracy in nasal samples.

While his previous research highlights the invention of RAPID (Real-time Accurate Portable Impedimetric Detection prototype 1.0), a COVID-19 testing kit which uses screen-printed electrodes, this new research published in PNAS presents LEAD (Low-cost Electrochemical Advanced Diagnostic), using the same concept as RAPID but with less expensive materials. De la Fuente's current test reduces costs from $4.67 per test (RAPID) to $1.50 per test (LEAD) just by changing the building material of the electrodes.

"Both RAPID and LEAD work on the same principle of electrochemistry," says de la Fuente. "However, LEAD is easier to assemble, it can be used by anyone and the materials are cheaper and more accessible than those of RAPID. This is important because we are using an abundant material, graphite, the same graphite used in pencils, to build the electrode to make testing more accessible to lower-income communities."

This figure, adapted from the paper, shows the functionalization steps of LEAD which prepares the electrodes to bind to the sample. The height of the peaks indicates whether the sample is negative or positive. Because the SARS-CoV-2 spike protein in a positive sample binds to the electrode, it inhibits the emitted signal and produces a smaller peak.

LEAD's functionalization and sample diagnosis take less than a few hours and can be made for a fraction of some of the most inexpensive tests on the market. Future steps for LEAD are twofold.

"Currently, we are working to improve the technology and stability of our tests," says de la Fuente. "We will always be looking for ways to make the most effective version of LEAD, but we are also working to find industry partners and conduct more clinical studies to push the use of LEAD for COVID testing as soon as possible."

While COVID-19 is the top priority, de la Fuente's tests can also detect other transmissible diseases, keeping this research relevant in the future.

"Another area of future research for our test design is multiplexing, which will allow us to detect multiple viruses and bacteria in a sample," says de la Fuente. "Once COVID is relatively controlled, we can use LEAD to detect the flu, Herpes, bacterial infections, and even certain biomarkers."

LEAD's cost and time efficiency may help it become one of, if not the first, electrochemical COVID-19 tests on the market in the near future and its fundamental process of sample detection could keep it on the market indefinitely.

Explore further
Rapid COVID-19 diagnostic test delivers results within 4 minutes with 90% accuracy
More information: Lucas F. de Lima et al, Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes, Proceedings of the National Academy of Sciences (2021). DOI: 10.1073/pnas.2106724118
Journal information: Proceedings of the National Academy of Sciences
 

Heliobas Disciple

TB Fanatic
Schools started back up last week in Florida. Gov Desantis has said no mask mandates allowed at any schools.

Here are some headlines:


PALM BEACH COUNTY Aug 13 2021
440 students quarantine in one Florida county due to COVID-19, two days after start of school year
EXCERPT:
A total of 440 students have been quarantined in Palm Beach County, Florida, due to COVID-19, just two days after the start of the school year, the Palm Beach County School District told ABC News.
The district kicked off the school year with in-person classes on Tuesday for the first time since last March.


BREVARD COUNTY Aug 13 2021
More than 470 Covid cases and 1,000 quarantined after the first week of school in a Florida county
EXCERPT:
Just days after fall classes started for Florida's Brevard Public Schools and after the school board voted against a mask requirement, there are more than 470 Covid-19 cases among students and teachers and roughly 1,060 people are in quarantine, according to the latest data from the district.
Of the 473 positive cases, roughly 385 are students and 88 are employees, the data shows. The cases are distributed across more than 50 elementary, middle and high schools and account for less than 1% of the district's total student population, which is around 73,000. Classes began on Tuesday.



HILLSBOROUGH COUNTY Aug 16 2021
5,600 students in Florida quarantined due to COVID-19
EXCERPT:
Aug. 16 (UPI) -- Nearly 5,600 students in a single Florida county as well as hundreds of its teachers have either tested positive for COVID-19 or have come into contacted with a positive case, officials said Monday, as the state's Republican governor continues to fight to prevent schools from mandating face masks.
The Hillsborough County School Board, which serves nearly 230,000 students in west central Florida that includes Tampa, said in a statement that as of 7 a.m. 5,599 students and 316 teachers were either in quarantine or isolation.
 

marsh

On TB every waking moment
View: https://www.youtube.com/watch?v=qz3KdYd081A
35:19 min

NYC Goes FULL 1984 Mandating Vaccine Passport And ID For Building Entry With NO Medical Exemption

Aug 17, 2021


Tim Pool


NYC Goes FULL 1984 Mandating Vaccine Passport And ID For Building Entry With NO Medical Exemption. Democrat mayor DeBlasio signed the executive order on the 16th to go into effect on the 17th. While Democrats have consistently advocated for the dystopian policy Republicans have rejected it. Now several cities are mandating vaccine proof. In the most alarming developed NYC confirmed to Timcast that there is no medical exemption and those with underlying conditions will be barred services. Now NYTimes is reporting the US will begin recommending COVID booster shots after 8 months.
 

Valann

Contributing Member
(fair use applies) EMPHASIS MINE

Sources: US to recommend COVID vaccine boosters at 8 months
ZEKE MILLER
Mon, August 16, 2021, 10:54 PM

WASHINGTON (AP) — U.S. experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot, to ensure lasting protection against the coronavirus as the delta variant spreads across the country.

Federal health officials have been actively looking at whether extra shots for the vaccinated would be needed as early as this fall, reviewing case numbers in the U.S. as well as the situation in other countries such as Israel, where preliminary studies suggest the vaccine’s protection against serious illness dropped among those vaccinated in January.

An announcement on the U.S. booster recommendation was expected as soon as this week, according to two people familiar with the matter who spoke to The Associated Press on the condition of anonymity to discuss internal deliberations.

Doses would only begin to be administered widely once the Food and Drug Administration formally approves the vaccines. That action is expected for the Pfizer shot in the coming weeks.

Last week, U.S. health officials recommended boosters for some with weakened immune systems, citing their higher risk of catching the virus and evidence that the vaccines' effectiveness waned over time.

The director of the National Institutes of Health, Dr. Francis Collins, said Sunday the U.S. could decide in the next couple weeks whether to offer coronavirus booster shots to Americans this fall.

Among the first to receive them could be health care workers, nursing home residents and other older Americans, who were some of the first Americans to be vaccinated once the shots received emergency use authorization last December.

Since then, more than 198 million Americans have received at least one dose of a COVID-19 vaccine according to the Centers for Disease Control and Prevention, with more than 168 million fully vaccinated. Still, the country is experiencing a fourth surge of virus cases due to the more transmissible delta variant, which is spreading aggressively through unvaccinated communities but is also responsible for an increasing number of so-called “breakthrough infections” of fully vaccinated people.

Israel, which exclusively administered the Pfizer shot, has been offering a coronavirus booster to people over 60 who were already vaccinated more than five months ago in an effort to control its own surge in cases from the delta variant.

For months, officials had said data still indicated that people remain highly protected from COVID-19, including the delta variant, after receiving the two-dose Pfizer or Moderna regimen or the one-shot Johnson & Johnson vaccine. But U.S. health officials made clear Sunday they are preparing for the possibility that the time for boosters may come sooner than later.

“There is a concern that the vaccine may start to wane in its effectiveness,” Collins said. “And delta is a nasty one for us to try to deal with. The combination of those two means we may need boosters, maybe beginning first with health care providers, as well as people in nursing homes, and then gradually moving forward” with others, such as older Americans who were among the first to get vaccinations.

He said because the delta variant only started hitting the U.S. hard in July, the “next couple of weeks” of case data will help the U.S. make a decision.

Officials were continuing to collect information as well about the J&J vaccine, which was only approved in the U.S. in late February, to determine when to recommend boosters, one of the officials said.

The White House has said that even though the U.S. has begun sharing more than 110 million vaccine doses with the world, the nation has enough domestic supply to deliver boosters to Americans should they be recommended by health officials.

Global health officials, including the World Health Organization, have called on wealthier and more-vaccinated countries to hold off on booster shots to ensure the supply of first doses for people in the developing world.
How convenient! 8 months. When did a lot of people start get vaccinated? About 8 months ago. January- February timeline.
 

TammyinWI

Talk is cheap
:bwl:
I am afraid that I believe that this is happening, but how common? I was floored when I saw a cellphone vid of some guy in med scrubs smothering an old guy in a hospital room, with a pillow, and it was so disturbing I could not bring myself to post it.

Florida hospital caught trying to MURDER covid patient to boost death numbers
08/17/2021 / By Ethan Huff

Just as many have warned is taking place, the Branch Covidians are now actively trying to kill people so they can blame it on “covid” and pad the official plandemic numbers.

The latest incident occurred at Sarasota Memorial Hospital (SMH) in Florida where medical personnel were caught refusing to administer antibiotic drugs to a patient who contracted pneumonia in an effort to terminate his life.

According to Dr. Stephen Guffanti, who was admitted to SMH back in August and shared a room with the patient in question, workers at the hospital refused to order the drugs. When Guffanti offered to help the man get what he needed, the hospital put Guffanti in restraints as if he was a mad man.

“This unbelievable story appears to be an effort by those in power to COVID-Kill the middle-aged man by not providing to him the anti-biotics needed to kill pneumonia,” reported The Gateway Pundit (TGP) about the disturbing incident – a video about it is available for viewing online.

Guffanti later learned that the man with pneumonia who needed antibiotics was put on a ventilator instead. Ventilators, as you probably know, have not been working for the Chinese Virus and are known to kill many of the people on whom they are placed.

Guffanti placed in solitary confinement for trying to help sick patient
A medical doctor, teacher, tutor and author who works as a preventive medicine physician in Sarasota, Guffanti says he was placed in solitary confinement as punishment for trying to help the sick man get the antibiotics he needed.

Guffanti says he was removed from the room, put into four-point restraints, and carted off to solitary confinement for four hours before signing out “against medical advice.” He later held a press conference at SMH to talk about what happened to him.

It is apparently now a crime in America for a doctor to advocate for the health of others when doing so goes against the Wuhan coronavirus (Covid-19) plandemic narrative.

The only “safe and effective” treatments for the Chinese Virus, at least according to the government and Big Pharma, are Chinese-made face masks and Donald “father of the vaccine” Trump’s “Operation Warp Speed” injections. Anything else is considered a “crime” worthy of being restrained and placed in solitary confinement like a terrorist.

“Best to avoid hospitals and all health care settings at the moment,” wrote one commenter at TGP. “It’s very likely this is happening everywhere.”

Since the American medical system refuses to acknowledge the benefits of hydroxychloroquine (HCQ), ivermectin, zinc, green tea, pine needle tea and the many other safe, effective and inexpensive remedies that exist for the Fauci Flu, we would tend to agree with that commenter’s sentiments.

“The NIH COVID Treatment Guidelines are behind all this,” wrote another. “Some doctors use these like a Bible. The NIH is out to kill people in more ways than one, I’m afraid. No antibiotics in the treatment guidelines addressing elevated white cells.”

“The bacterial pneumonias people are suffering are a result of wearing masks,” commented another, speculating as to the true cause behind the latest “wave” of hospitalizations that are being reported.

“The proof of that comes from bodies exhumed after the Spanish flu. Those autopsies proved they did not die from Spanish flu but from the masks they wore. Fauci wrote a paper on it more than 10 years ago. Fauci has known all along masks would kill.”

 

DHR43

Since 2001
(fair use applies) EMPHASIS MINE

Sources: US to recommend COVID vaccine boosters at 8 months
ZEKE MILLER
Mon, August 16, 2021, 10:54 PM

WASHINGTON (AP) — U.S. experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot, to ensure lasting protection against the coronavirus as the delta variant spreads across the country.

Federal health officials have been actively looking at whether extra shots for the vaccinated would be needed as early as this fall, reviewing case numbers in the U.S. as well as the situation in other countries such as Israel, where preliminary studies suggest the vaccine’s protection against serious illness dropped among those vaccinated in January.

An announcement on the U.S. booster recommendation was expected as soon as this week, according to two people familiar with the matter who spoke to The Associated Press on the condition of anonymity to discuss internal deliberations.

Doses would only begin to be administered widely once the Food and Drug Administration formally approves the vaccines. That action is expected for the Pfizer shot in the coming weeks.

Last week, U.S. health officials recommended boosters for some with weakened immune systems, citing their higher risk of catching the virus and evidence that the vaccines' effectiveness waned over time.

The director of the National Institutes of Health, Dr. Francis Collins, said Sunday the U.S. could decide in the next couple weeks whether to offer coronavirus booster shots to Americans this fall.

Among the first to receive them could be health care workers, nursing home residents and other older Americans, who were some of the first Americans to be vaccinated once the shots received emergency use authorization last December.

Since then, more than 198 million Americans have received at least one dose of a COVID-19 vaccine according to the Centers for Disease Control and Prevention, with more than 168 million fully vaccinated. Still, the country is experiencing a fourth surge of virus cases due to the more transmissible delta variant, which is spreading aggressively through unvaccinated communities but is also responsible for an increasing number of so-called “breakthrough infections” of fully vaccinated people.

Israel, which exclusively administered the Pfizer shot, has been offering a coronavirus booster to people over 60 who were already vaccinated more than five months ago in an effort to control its own surge in cases from the delta variant.

For months, officials had said data still indicated that people remain highly protected from COVID-19, including the delta variant, after receiving the two-dose Pfizer or Moderna regimen or the one-shot Johnson & Johnson vaccine. But U.S. health officials made clear Sunday they are preparing for the possibility that the time for boosters may come sooner than later.

“There is a concern that the vaccine may start to wane in its effectiveness,” Collins said. “And delta is a nasty one for us to try to deal with. The combination of those two means we may need boosters, maybe beginning first with health care providers, as well as people in nursing homes, and then gradually moving forward” with others, such as older Americans who were among the first to get vaccinations.

He said because the delta variant only started hitting the U.S. hard in July, the “next couple of weeks” of case data will help the U.S. make a decision.

Officials were continuing to collect information as well about the J&J vaccine, which was only approved in the U.S. in late February, to determine when to recommend boosters, one of the officials said.

The White House has said that even though the U.S. has begun sharing more than 110 million vaccine doses with the world, the nation has enough domestic supply to deliver boosters to Americans should they be recommended by health officials.

Global health officials, including the World Health Organization, have called on wealthier and more-vaccinated countries to hold off on booster shots to ensure the supply of first doses for people in the developing world.
Just making sure of the "effectivity" of the pricks.

I trust you all understand what the purpose of the pricks is?
 
How long is this dumb virus going to be around? My Mom died from covid this past February. She was perfectly healthy before that. Get vaccinated, she wanted to and I finally did
I’m sorry about your Mom. But from the data so far, it looks like this virus is going to be with us, well, forever.
 

inskanoot

Veteran Member
(fair use applies)

EMPHASIS IN ORIGINAL ARTICLE (not added by me)

Fluvoxamine- An ‘Inexpensive’ Anti-Depressant Emerging As A Leading Drug Candidate To be Repurposed To Treat COVID-19
Aug 14, 2021

Fluvoxamine, an inexpensive anti-depressant drug is now emerging as a potential candidate to be repurposed to treat COVID-19.

Speculations are adrift that Canada might be the first country to approve its usage to treat COVID-19 followed by the United States, India, Brazil and South Africa.

Fluvoxamine, sold under the brand name Luvox among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class which is used primarily for the treatment of depression disorder and obsessive–compulsive disorder (OCD). It is also used to treat anxiety disorders, such as panic disorder, social anxiety disorder, and post-traumatic stress disorder.

Initially fluvoxamine was identified through computational silico studies for its binding ability to both the human ACE2 receptors and also to the spike proteins of the SARS-CoV-2 coronavirus thus preventing binding between the two and acting to a certain degree as an antiviral.
Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective

Vitro studies also confirmed its ability to reduce Sars-CoV-2 viral loads through interference with the ACE2/TMPRSS2 receptors. Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine show antiviral activity against the novel variants in vitro

Another study showed that fluvoxamine could also act as an antiviral via affecting the membrane of the SARS-CoV-2 coronavirus and even suggested its usage as a prophylaxis.
Low-dose fluvoxamine modulates endocytic trafficking of SARS-CoV-2 spike protein: a potential mechanism for anti-COVID-19 protection by antidepressants

However it should be noted that fluvoxamine, an FDA-approved antidepressant, works best by being an S1R agonist. Although fluvoxamine may inhibit SARS-CoV-2 by interfering with endosomal viral trafficking, most studies suggest that its main benefit is likely to be as an inhibitor of excess cytokine production. Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

Fluvoxamine has also been shown to modulate the response to bacterial sepsis in a beneficial manner in a mouse model, preventing inflammation as well as sepsis hence its usage is beneficial in COVID-19. Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis - PubMed

This study published in the Science Translational Medicine journal mechanistically explained that S1R (ER-resident protein sigma-1 receptor]) restricts the endonuclease activity of the ER (endoplasmic reticulum) stress sensor IRE1 and cytokine expression but does not inhibit the classical inflammatory signaling pathways. These findings have substantial clinical implications as it shows that fluvoxamine, an antidepressant therapeutic with high affinity for S1R, protects mice from lethal septic shock and dampens the inflammatory response in human blood leukocytes. The s ame cytokine storm that is mentioned in this study is also an inflammation-causing symptom in COVID-19.

In a double-blind, randomized, placebo-controlled study of 152 outpatients with confirmed SARS-CoV-2 infection, none of 80 patients receiving fluvoxamine compared to 6 of 72 patients receiving placebo experienced clinical deterioration over 15 days (P = 0.009). Effect of Fluvoxamine vs Placebo on Clinical Deterioration in Outpatients With Symptomatic COVID-19

The results of this study prompted another case study during a late 2020 COVID-19 outbreak at a horse racing track in California. Sixty-five track workers volunteered to receive 50 mg of fluvoxamine twice a day, and the 48 who declined were used as comparison. Similar to the first study, none who received fluvoxamine had clinical deterioration after 14 days; whereas, 12.5% of those who didn't receive fluvoxamine did and 60% still had symptoms, according to the results published in Open Forum Infectious Diseases. Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19

A larger study of fluvoxamine in 1,100 patients is currently underway (NCT04668950) and also another 3 more clinical trials are underway in various countries.

Numerous other studies are also suggesting repurposing Sigma-1 Receptor Ligands such as fluvoxamine for COVID-19 therapy. Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?

Nevertheless, in the race to find treatments to prevent and treat coronavirus infections, fluvoxamine could be a useful addition. If given during the initial fever and coughing phase of COVID-19, the drug could reduce the number of patients who develop the dangerous second phase of COVID-19, characterized by the cytokine storm and subsequent lung damage.

Given that the drug’s therapeutic effects in COVID-19 may be mediated via the S1R, it would certainly be worth studying in detail its effectiveness.

Another study led by the Duke Clinical Research Institute is looking at whether three existing medications would treat mild-to-moderate COVID-19 effectively.
The three repurposed medications, already approved by the U.S. Food and Drug Administration for other uses, are: 1)Ivermectin, used to treat parasitic infections; 2)Fluticasone, an inhaled steroid commonly prescribed for asthma and chronic obstructive pulmonary disease; and 3)Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), often prescribed for depression. Nationwide Clinical Study Expands Platform to Test Medications to Treat Mild-to-Moderate COVID-19 - DCRI

However the first drug Ivermectin is already being discounted as a lot of emerging data is showing that it does not work with the newer variants.

Meanwhile a new Canadian led trial involving fluvoxamine to treat COVID-19 that was just completed by researchers from McMaster University is creating a stir in both the medical community and also the media.

Various Canadian media are calling the trial results which are going to be published soon as “Among the most important findings since the COVID pandemic began.”

The inexpensive anti-depressant curbed the number of COVID-19 patients ending up in hospital by 30 per cent, making it a potential breakthrough treatment for a virus that continues to spread widely, the Canadian-led clinical trial is reporting.


Once confirmed by more research, the drug, fluvoxamine, would be one of the most effective and convenient to treat the virus outside of pricey new “monoclonal antibodies.” They typically have to be administered in a hospital, as opposed to a pill taken orally at home.

The drug fluvoxamine is given early in the course of the disease, potentially staving off more severe outcomes and their cost to the health-care system.

This relatively large, randomized controlled study was carried out in Brazil and spearheaded by co-principal investigator Dr Ed Mills and other researchers associated with McMaster University in Ontario. It was part of their larger trial that is testing a number of potential drug treatments against COVID.

The study team looked at the rate of hospitalization among patients with test-confirmed infection. Most of the eight studied drugs, including much-debated candidates such as hydroxychloroquine and ivermectin, showed no detectable benefits.

However the study found that 77 of the 739 subjects who were randomly selected to receive fluvoxamine ended up spending less than six hours in an emergency department or being admitted to hospital, compared to 108 of the 733 who were administered a placebo.

The trial’s independent data-safety monitoring board, which keeps an eye on results that are blinded to the actual researchers, ordered the trial stopped after seeing the positive numbers, said Dr Mills.

It confirms smaller, earlier studies that had shown promise for the drug fluvoxamine that was used to treat obsessive-compulsive disorder and its anti-inflammatory properties that is beneficial for COVID-19.

Dr Mills, a part-time professor at McMaster told Thailand Medical News, “This is among the most important findings since the COVID pandemic began.”

He added, “You have a Canadian-led study that has the potential to change guidance around the world for a very cheap treatment. This is a massive finding of benefit to public health.”

The drug fluvoxamine costing about US$4 per 10-day course, could be especially important in poorer countries with low vaccination rates and that lack the ability to acquire more expensive therapies, he said.

The study team including co-principal investigator Dr. Gilmar Reis of Brazil’s Pontificia Universidade Catòlica de Minas Gerais plan to post a paper outlining their results on a pre-print site and submit it to a journal for publication within days, the study findings are already being peer reviewed.

The study team had already presented their findings to a meeting of the National Institutes of Health (NIH) in the U.S. last week and to World Health Organization experts. And the team includes world-renowned clinical trial experts from McMaster, including Dr Gordon Guyatt, credited with coining the term “evidence-based medicine.”

Dr David Boulware, an infectious disease specialist at the University of Minnesota and national co-chair of the NIH’s own trial investigating potential COVID treatments commented, “This is really the first large trial that shows a benefit for fluvoxamine or any oral medication. It’s inexpensive, it’s generic and it’s going to be used. So in that sense it’s a world-wide drug.”

Dr Boulware, who was co-author of one of the earlier, small studies of fluvoxamine and COVID, said some of the monocolonal antibody treatments given emergency approval by regulators have greater effectiveness, but their high cost and mode of administration limit how widely they are used.

Head of the infectious disease department at Queen’s University’s medical school, Dr Gerald Evans said, “This trial did back up those earlier studies and was headed by respected researchers. The findings are impressive. Everything that I’ve seen does suggest it’s an honest, true signal. This is the first drug that has shown a consistent benefit for COVID 19, which separates it from others being studied including Ivermectin which is now deemed to be ineffective.”

However before the trial studies were released, those in the inner circles including Thailand Medical News started to stockpile on the drug and already it was noticed that there is a short supply of the drug and prices are already starting to skyrocket.

Thailand Medical News found that in New York the drugs were going now at US$320 for sixty tablets and supplies were short and a doctor’s prescription was needed.

In Sydney and Thailand, a doctor‘s prescription was also needed and prices were going for US$180 for sixty tablets in Australia while in Thailand it was going for US$60. However there are no longer supplies available in Thailand nor in Australia.

There were numerous sites selling so called generic versions in Thailand, India and also from Pakistan but most were found to either be substandard or fake.

Hence the question arises, who is controlling the supply of these drugs and why is there all of a sudden a shortage.

If the demand for fluvoxamine does increase, it is expected to cause extreme drug shortages in the US market.

It was reported that in 1994, fluvoxamine became the US Food & Drug Administration's (FDA's) first approved SSRI, although it has been used internationally in clinical practice since 1983.

Solvay was the first and exclusive manufacturer, selling fluvoxamine under the brand name Luvox.

The U.S.FDA currently reports that seven companies that still hold approved abbreviated new drug applications to manufacture fluvoxamine, and several other firms have entered and exited the market over the past decade.

Unlike many other generic drugs that are made primarily in India, much of the fluvoxamine is produced in US facilities.

In India, it was found that one two companies are currently making generic fluvoxamine but the quality is inferior plus the U.S FDA had discovered contaminants in them before had had recalled these products and subsequently banned these Indian products in 2014.

Thailand Medical News checked and found that there are at least five manufacturers in the United States who still make the active pharmaceutical ingredient known as fluvoxamine. However their production is extremely small.

Drug shortages are less likely to occur when there are multiple active ingredient manufacturers, when some of that production is based in the United States, and when there is continued strong demand for the drug.

Already demand for fluvoxamine continues to be substantial for OCD, as well as off-label for social anxiety disorder and other conditions.

Drugs.com lists the cost for a bottle of 100 25-mg oral tablets around $79, but the US market demand was enough to pull in approximately US$28 million in sales from September 2018 to September 2019, according to Upsher Smith, one of the drug's generic manufacturers.

However despite the promising role of fluvoxamine to treat COVID-19, if nothing is done to scale up fluvoxamine production and to keep prices down, the whole purpose of finding cheap therapeutic solutions to treat COVID-19 would be pointless as already it is difficult for common people to find a bottle of fluvoxamine anywhere around the world at present!

For more on Fluvoxamine and COVID-19, keep on logging to Thailand Medical News. (Please note that I do not have the luxury of having an editor to peruse through all my writings which might not be perfect grammatically and also I do not have the luxury of time on my side as I also handle numerous other websites, research and community projects. Thailand Medical News is basically a one man show! I would however appreciate your help in donating to support all these efforts. Sponsorship - Thailand Medical News Do not be a ‘Cheap Charlie’ and simply read and ignore the plea for help. Those who cannot donate, do not send me emails with your negative comments about the standard or my writing skills as you know what you could do with those and also hopefully you will end up as one of the COVID-19 statistical figures! Thank You.)

Do not attempt to self-prescibe or self-treat using fluvoxamine. Always consult a licensed medical doctor first. (Provided he or she knows anything about SARS-CoV-2 and COVID-19!)
Yuck. That falls in with the agenda.
 

WTSR

Veteran Member

The United States will begin widely distributing Covid-19 booster shots next month as new data shows that vaccine protection wanes over time, top U.S. health officials announced Wednesday.
It’s now “very clear” that immunity starts to fall after the initial two doses, and with the dominance of the delta variant, “we are starting to see evidence of reduced protection against mild and moderate disease,” according to the statement signed by CDC Director Dr. Rochelle Walensky, acting FDA Commissioner Dr. Janet Woodcock, White House chief medical advisor Dr. Anthony Fauci and other U.S. health leaders.

“Based on our latest assessment, the current protection against severe disease, hospitalization, and death could diminish in the months ahead, especially among those who are at higher risk or were vaccinated during the earlier phases of the vaccination rollout.”
As a result, U.S. agencies are preparing to offer booster shots to all eligible Americans beginning the week of Sept. 20, starting eight months after their second dose of Pfizer or Moderna’s vaccines, officials said. While they said recipients of Johnson & Johnson’s single-shot vaccine will likely need boosters, they are awaiting more data in the next few weeks before making a formal recommendation.
“With those data in hand, we will keep the public informed with a timely plan for J&J booster shots as well,” the officials said.
 

ChicagoMan74

ULTRA MAGA

The United States will begin widely distributing Covid-19 booster shots next month as new data shows that vaccine protection wanes over time, top U.S. health officials announced Wednesday.
It’s now “very clear” that immunity starts to fall after the initial two doses, and with the dominance of the delta variant, “we are starting to see evidence of reduced protection against mild and moderate disease,” according to the statement signed by CDC Director Dr. Rochelle Walensky, acting FDA Commissioner Dr. Janet Woodcock, White House chief medical advisor Dr. Anthony Fauci and other U.S. health leaders.

“Based on our latest assessment, the current protection against severe disease, hospitalization, and death could diminish in the months ahead, especially among those who are at higher risk or were vaccinated during the earlier phases of the vaccination rollout.”
As a result, U.S. agencies are preparing to offer booster shots to all eligible Americans beginning the week of Sept. 20, starting eight months after their second dose of Pfizer or Moderna’s vaccines, officials said. While they said recipients of Johnson & Johnson’s single-shot vaccine will likely need boosters, they are awaiting more data in the next few weeks before making a formal recommendation.
“With those data in hand, we will keep the public informed with a timely plan for J&J booster shots as well,” the officials said.
Y'all freaking out over this? After boosters...next up will be seasonal combination flu/SARS-Cov vaccines. Quite possibly by mid-2022 or 2023. This ain't just going away.
 

mzkitty

I give up.
Billet just posted this on a separate thread. It should be here too. Ph.D. speaking at a school board meeting:

4:00

 
Y'all freaking out over this? After boosters...next up will be seasonal combination flu/SARS-Cov vaccines. Quite possibly by mid-2022 or 2023. This ain't just going away.
Follow.

The.

Money.

Purposefully induced fear of all things COVID is making a LOT of money for the pharmaceutical industry and their capital investors/stock holders.


intothegoodnight
 

marsh

On TB every waking moment

Vax-entration Camps? Australian Government Builds “Mandatory Quarantine Facilities”, Officials Say Jab Is “Golden Ticket to Freedom”

By Julian Conradson
Published August 18, 2021 at 7:30am

Screenshot_20210818-030523_Drive-913x479.jpg


Part of Australia’s Mandatory Covid Quarantine Center’s Master Plan Blueprints
In late 2019, before the China-virus was known to the world, very few – if any – people could have even imagined that a civilized western nation would be building facilities that government thugs would be forcing citizens into against their will.

Well, a year-and-a-half later, that’s exactly where we are.

It didn’t take long in 1938 Germany, either.

The Government of Australia will be building what they call a “mandatory quarantine accommodation” which is set to open its first phase in “early 2022.” This will be the second of such facilities in the country and when it is finished it will be able to hold up to 3,000 in isolation as they quarantine.

1629326629444.png

As if it was straight out of Orwell’s 1984, the camp will be named ‘The Center for National Resilience’ and government health officials are calling the experimental jab the golden “ticket to freedom.”

Back to reality – Police Officers who are accompanied by the military have already been coming to people’s homes and taking them away as they conduct random “welfare checks” and follow-up tips about rule-breakers who have been ratted out by their fellow citizens.

Sound familiar?

This video shows the Covid Gestapo in action:

View: https://youtu.be/R1nPJZSO3Pk
.27 min

As of now, they are mostly being taken to hotels, but some will go to the already functioning and smaller Vax-entration camp in the northern part of the country.

Police have even resorted to just flat-out assaulting non-maskers, even if they are children.

View: https://twitter.com/WinterAsh12/status/1427627023212576769


It’s gotten to this point after a year and a half, where will it be in a year from now?

Australians were sent letters in the mail that detailed the plans of the Government’s new “important project.” It also informs them about an upcoming “community information session” where citizens can join and listen to corrupt health officials tell them why they “need the center.”

1629326503795.png

In a project summary posted to Australia’s “quarantine hub” website, it details their expectations for restrictions to continue for as long as 3 years and that the mandatory facilities would “improve compliance” and “change attitudes” among other things.
“With COVID-19 quarantine requirements expected to continue in some form at least over the next two to three years, the Victorian Government has further committed to investigating alternative models of mandatory quarantine, including purpose-built Alternative Quarantine Accommodation outside of Melbourne’s Central Business District

The options are assessed, amongst other factors, on their ability to deliver the following benefits

..More tailored response options for the Government that are commensurate to risk levels and help improve compliance.”
The full project summary can be found here.

If you think there’s no way this will come to America, think again.

The CDC has already
published an approach that discusses building these types of covid-internment camps, using terms like “green zone” and “shielding approach” as euphemisms to make it more palatable.

It’s only a matter of time until they try something like this here.
 

marsh

On TB every waking moment

Washington Hospital Removing Patients From Transplant List for Being Unvaccinated

By Cassandra Fairbanks
Published August 18, 2021 at 2:05pm
00-191.jpg

The University of Washington Medical Center has kicked “several patients” off their transplant waiting list for not being vaccinated, according to reports.


The report says that the hospital began denying organ transplants to the unvaccinated in June 2021.

Seattle station KTTH reports, “UW Medicine removed a 64-year-old patient from the transplant waitlist. He says he was on the list for two and a half years. The hospital made the decision after they learned the patient refused to be vaccinated against COVID. They said they would consider adding him back to the waitlist should he satisfy their ‘compliance concerns.’”

“Last week, one vaccine-hesitant patient came forward. He says he was told the vaccine was mandatory before he could get a necessary liver transplant. The hospital does not deny any of the allegations,” the report continued. “In June, Sam Allen of Monroe learned that his heart transplant surgery was on the line over his refusal to get the COVID vaccine.”

Allen is suffering from mitral valve regurgitation, tricuspid valve regurgitation, aortic valve regurgitation, aneurism of thoracic aorta, and dilated cardiomyopathy.

The outlet explained that he has “three leaky heart valves impact the blood pumping into his lungs” so he has not been wearing a mask, due to difficulty breathing.

“The cardiologist called me and we had a discussion, and he informed me that, ‘well, you’re going to have to get a vaccination to get a transplant.’ And I said, ‘well that’s news to me. And nobody’s ever told me that before.’ And he says, ‘yeah, that’s our policy,’” Allen recalled.

Allen told the doctor that he would not be getting the vaccination.
“As a person who has spent much time and money at UWMC as a heart failure patient, I am being told I cannot get care for my condition unless I take an injection that has shown to cause cardiac problems,” he wrote. “It seems that a wise choice would be to not make a panic move and run to get injected with the experimental gene therapy until more is known.”
A few days later, he was notified that he had been removed from the United Network for Organ Sharing list.

“Your name has been removed from the waitlist at the University of Washington Medical Center. This was done in follow-up to your recent conversation with providers regarding the heart transplant selection committee’s concerns about compliance with COVID-19-related policies and recommendations,” the letter read. “We can re-assess you for reinstatement on the waiting list should the compliance concerns resolve in the future or, if you wish, refer you to another center for evaluation in the meantime.”

KTTH says that the letter was signed by UW Medicine and the Cardiac Transplant/Advanced Heart Failure Therapies Selection Committee.

Read the shocking full report here.
 

marsh

On TB every waking moment

Fauci Flouts 'Concern About Personal Liberties'

WEDNESDAY, AUG 18, 2021 - 12:50 PM
Authored by Chris Talgo via The Epoch Times,

For the past 18 months, Americans have had their personal liberties trampled upon by a plethora of politicians and public health officials.

First, we were told to hunker in place for two weeks, to “stop the spread” and “flatten the curve.”

Of course, those two weeks turned into several months.

Second, we were told to wear masks at all times in all places, until the vaccine arrived.

The vaccine arrived more than eight months ago, yet in many places in America, masks are still required.

Third, we were told that if we get the vaccine, we could return to life as we knew it pre-pandemic.

Well, for those of us who took the vaccine, that hasn’t turned out to be true.

Yet, in perhaps the most startling development yet, Dr. Anthony Fauci has now declared that all Americans who choose (for whatever reason) not to receive the vaccine will have to “put aside all of these issues of concern about liberties and personal liberties and realize we have a common enemy and that common enemy is the virus.”


So, personal liberties be damned. According to Fauci, an unelected bureaucrat, Americans must roll up their sleeves and receive a COVID-19 vaccination, whether they like it or not.

Furthermore, they must receive a vaccine that has not been fully approved by the Food and Drug Administration.

And, they must do so even if they had COVID-19, even though natural antibodies have been proven to be superior to the vaccine.

Obviously, this makes no sense.

According to Fauci, while appearing on CBS News’ “Face the Nation,” “Well, what’s coming next is that we are going to have to continue to get people vaccinated so that right now, even in states in which you have a good relative proportion of people vaccinated, you have to get the overwhelming proportion of people vaccinated.”

Once again, no mention of natural antibodies or that Americans with certain medical conditions should refrain from receiving the vaccine.

Fauci added, “And that gets to the controversial issue of mask wearing and the mandating of things mandating of vaccines, for example, for teachers and people in the personnel in the school, but also in situations as uncomfortable as we know and controversial as we know it is with regard to masks wearing, particularly in the situation in schools, we’ve just got to realize that we’re dealing with a public health crisis. And the more you get infections, the more spread you get, the greater opportunity the virus has to continue to evolve and mutate.”

The Constitution makes no mention of a suspension of basic liberties during a pandemic. However, that has not stopped Fauci and others from usurping Americans’ personal liberties under the guise of the pandemic.

In the early days of the pandemic, we witnessed countless examples of governors, mayors, and many others who made a mockery of personal liberties with their unconstitutional orders.

Perhaps New Jersey Gov. Phil Murphy embodied this best when he said, referring to his lockdown order, “I wasn’t thinking of the Bill of Rights when we did this. …

We went to the scientists who said people have to stay away from each other.”

Unfortunately, Murphy’s quip was all-but ignored by the mainstream media, who have openly celebrated and encouraged the suspension of personal liberties throughout the pandemic.

What’s more confusing/ominous is that the vast majority of Americans seem to have accepted the suspension of personal liberties for the past 18 months.

Aside from some protests here and there, it appears most Americans have rolled over, content to have their fundamental liberties put in a state of flux while the pandemic drags on.

And drag on it has.

The thing Americans need to understand is that COVID-19 will be here forever. Variants will come and go. But the never-ending fearmongering from our so-called leaders must end.

We the people must take it upon ourselves to call for an end to the permanent pandemic. We must make sure our personal liberties, which are paramount, remain robust—pandemic or not.
 

Chapulin

Veteran Member
The CDC was streaming a session this morning with a number of studies hitting the preprint sites today. We need to split hospitalization/death away from infection/mild symptoms. We are seeing 1-3% loss of effectiveness of the vaccines in fighting hospitalization/death including Delta. Pfizer has a competitive disadvantage in terms of infection/mild symptoms. But both mRNA vaccines with 2 doses are down around 70% for blocking infection/mild symptoms.

If your bar for world decisions is hospitalization/death you will advocate to keep the US at 2 doses and export as much as we can. If your bar for US decisions is blocking infection/mild symptoms to reduce spread then the booster shot is required with Delta and 8 month old jabs. With the indoor/mask season returning our economy will take less of a hit with boosters. The undercurrent in interviews is a concept that vaccinated people in environments dripping with Delta can get enough of a viral load to hospitalize without the booster. How much of this concern is related to waning effectiveness and how much of this concern is related to extreme spreading rates I can't tell.

The bar for effectiveness on the EUA was 50% blocking hospitalization/death. Our mRNA vaccines soared over that measure and even provided infection/mild symptoms protection against Alpha variants. We were ecstatic and we pushed the vaccinate or mask tag line. We were always looking at the new variants for the hint that one of them would push our current vaccines below the initial bar and could become dominant in the unvaccinated areas.

Delta was a curve ball that has put us under the infection/mild symptoms elevated bar and may chip away at the hospitalization/death rates higher bar in severe waves/older vaccinations. It is not an easy debate, but the time is now, not some future unknown killer variant.

We need to be an informed public about what the vaccines should protect us from while the medical pundits may have their own agendas. We know Delta, what it means for us is getting clouded in the argument. We have a segment of the US that has politicized masks and vaccines. We have a world with lacking infrastructure and political problems. Can we beat the virus with a world wide effort? Can we get back to "Normal" with a US focus?

How do we stop our extreme spread in the US and what protects our population from Travel in the US and the rest of the world?
 

marsh

On TB every waking moment

Health Officials Formally Recommend Booster Shots 8 Months After Vaccination
Traveling registered nurse Taylor Reed (R) receives a Covid-19 vaccination at Martin Luther King Jr. (MLK) Community Hospital on January 6, 2021 in the Willowbrook neighborhood of Los Angeles, California. - Deep within a South Los Angeles hospital, a row of elderly Hispanic men in induced comas lay hooked up …
PATRICK T. FALLON/AFP via Getty Images
HANNAH BLEAU18 Aug 2021327

U.S. health officials on Wednesday formally recommended booster shots for fully vaccinated individuals after 8 months of their vaccine series.

In a joint statement attributable to officials at the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and White House COVID-19 Response team, public health officials admitted they are beginning to see “evidence of reduced protection against mild and moderate disease” in those who have been vaccinated:
Based on our latest assessment, the current protection against severe disease, hospitalization, and death could diminish in the months ahead, especially among those who are at higher risk or were vaccinated during the earlier phases of the vaccination rollout.
The statement recommended booster shots, which they said are “needed to maximize vaccine-induced protection and prolong its durability.”

The officials said they developed a plan to offer the booster shots as early as this fall, pending an FDA evaluation of the safety and effectiveness of a third dose of Pfizer’s and Moderna’s mRNA vaccines, as well as approval from the CDC’s Advisory Committee on Immunization Practices (ACIP).

“We are prepared to offer booster shots for all Americans beginning the week of September 20 and starting 8 months after an individual’s second dose,” the joint statement read.

“At that time, the individuals who were fully vaccinated earliest in the vaccination rollout, including many health care providers, nursing home residents, and other seniors, will likely be eligible for a booster,” it continued.

Officials added that they will “begin efforts to deliver booster shots directly to residents of long-term care facilities at that time, given the distribution of vaccines to this population early in the vaccine rollout and the continued increased risk that COVID-19 poses to them.”

The health officials said they are still waiting to view data on if booster shots are needed for the single-dose Johnson & Johnson vaccine, but they anticipate it will, in fact, be the case.

“Our top priority remains staying ahead of the virus and protecting the American people from COVID-19 with safe, effective, and long-lasting vaccines especially in the context of a constantly changing virus and epidemiologic landscape,” they continued, vowing to “follow the science on a daily basis” and modify the plan as needed.

The health officials emphasized their efforts to continue to get as many people vaccinated as possible and “ensure people have accurate information about vaccines from trusted sources.”

The news follows reports of CDC data showing a “worrying drop” in vaccine efficacy over time, prompting the Biden administration to take action.
Just over 50 percent of the U.S. population is fully vaccinated, according to the CDC’s August 17 data.
 

marsh

On TB every waking moment

CDC Data Shows ‘Worrying Drop’ in Vaccine Efficacy over Time
1,213
CDC Director Dr. Rochelle Walensky speaks to the press after visiting the Hynes Convention Center FEMA Mass Vaccination Site on March 30, 2021 in Boston, Massachusetts. Dr. Walensky recently said she had a sense of impending doom as the rate of coronavirus infection has recently been rising across the U.S. …
Erin Clark-Pool/Getty Images
HANNAH BLEAU18 Aug 20212,731

Data from the Centers for Disease Control and Prevention (CDC) has demonstrated what anonymous administration officials described to Politico as a “worrying drop” in coronavirus vaccine efficacy over time, leading to the Biden administration’s conclusion to push vaccine booster shots.

“This is what moved the needle,” a senior Biden administration official said to Politico of the CDC’s report.

According to the outlet, the data looked at the effectiveness of the coronavirus vaccines at different points in time and found a “decline in the initial round of protection against Covid-19 [Chinese coronavirus] infection that’s coincided with a resurgence in cases driven by the more contagious Delta variant.”

The data, which the White House Covid-19 task force reviewed Sunday, is expected to become public this week. As a result, the Biden administration is expected to roll out its plan to push booster shots for fully vaccinated Americans, but details are still being worked out, as the Food and Drug Administration (FDA) needs authorize the booster shots. Notably, the FDA has not formally authorized any of the vaccines. Rather, they are all operating under emergency use authorization:
Officials are still finalizing the details of the booster plan, and the government is not expected to begin offering third shots from Pfizer and Moderna until mid-September at the earliest. The Food and Drug Administration must first authorize the booster shots, and the CDC will need to formally recommend that people get them eight months after completing their initial vaccination round.

But the move represents an acceleration of a process that had proceeded cautiously, as officials hunted for clear signs that the vaccines’ immunity was waning.

The plan for now doesn’t call for boosters for recipients of the single-dose Johnson & Johnson vaccine. Federal officials are awaiting results of a study by the drugmaker on the effectiveness of administering two J&J doses.
Last week, the CDC recommended a third vaccine dose for immunocompromised people, coinciding with the FDA’s ruling on the matter.

“Today’s action allows doctors to boost immunity in certain immunocompromised individuals who need extra protection from COVID-19,” the FDA’s acting commissioner Dr. Janet Woodcock said in a statement at the time.

Last month, Pfizer officials met with top U.S. health officials to discuss their request for authorization for a third coronavirus shot.
 

marsh

On TB every waking moment
View: https://www.youtube.com/watch?v=KkGj2FSasK0
59:40 min

Additional mRNA COVID-19 Vaccine for Moderately to Severely Immunocompromised People

Aug 18, 2021


Centers for Disease Control and Prevention (CDC)


During this COCA Call, presenters will discuss the current data on COVID-19 vaccines in immunocompromised people; the role of additional doses of mRNA COVID-19 vaccines, patients who should be considered to receive these additional COVID-19 vaccine doses, results from the August 13, 2021, Advisory Committee on Immunization Practices (ACIP) meeting, and CDC’s guidance on additional COVID-19 doses in immunocompromised people. This video can also be viewed at https://emergency.cdc.gov/coca/wmv/20...
 

marsh

On TB every waking moment
View: https://www.youtube.com/watch?v=UEXTtUOMjlI
4:35 min

This is when you can get COVID Booster Shot
Aug 18, 2021


Doctor Mike Hansen


Whether or not you are immunocomprimised (have a weakened immune system), we now have answers to when you can get a COVID booster shot…if you had either the Pfizer or Moderna vaccine.

There are about 9 million people in the US who are considered to be at least moderately immunocompromised. These are mostly people who are taking powerful immunosuppressive medications, like transplant recipients, cancer patients, and those with severe auto-immune conditions. Their immune system’s ability to respond to the vaccine is blunted, with a decreased antibody response. Vaccine effectiveness is estimated to around 60-70% in immunocompromised people, compared to 94% overall.

According to the CDC, data shows that vaccinated immunocompromised people have accounted for a large portion of COVID hospitalizations….They are 485 times more likely to end up in the hospital or die from Covid compared to non-immunocomprimised vaccinated people. Also, immunocomprimised are more likely to spread the virus, despite making up only 3% of the population.

But can we actually expect a booster shot to help them? There is currently an observational study at Johns Hopkins, that is yet to be published. They looked at people who received a 3rd dose. Based on that, the booster shot did help some of them to achieve higher antibody levels. Last week, the FDA gave EUA for the booster shot for some immunocompromised people, in conjunction with the CDC’s recommendation. So this is for both Moderna and Pfizer. But so far, there’s not enough available data to move forward for a booster shot for the J&J vaccine.

According to the CDC, this EUA is intended for people those who have moderate to severe immunosuppression and not people with chronic conditions for which there might be mild associated immunosuppression. For example, people with diabetes, chronic kidney disease, chronic liver disease, COPD…these patients have some degree of immunosuppression, but its not on the same level as the other conditions I mentioned. But you have people that fit into a category that is a real grey area, for example someone with rheumatoid arthritis taking drugs like methotrexate, hydroxychloroquine, leflunomide, or sulfasalazine, or drugs like humira and other biological agents.

According to the CDC, someone considered to be moderately to severely compromised in general, would be someone: • receiving active cancer treatment • someone with an organ or stem cell transplant • Advanced or untreated HIV infection • Someone getting high dose steroids for a prolonged time • Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)

Basically, the CDC is leaving it up to patients and their doctors to decide who needs an extra dose and when they should get it. And apparently, there won’t be a requirement for a doctor’s note or prescription. And so if that’s the case, basically anyone can say they are immunocompromised in order to get a booster shot….unless those administering the vaccine require proof of a qualifying immunocompromised condition. So that’s a messy situation that the CDC should further clarify. Otherwise, pretty much anyone can lie and get a 3rd shot.

And so what about those who are not considered to be immunocomprimised? The Biden administration is working on a plan for most Americans getting booster shots eight months after becoming fully vaccinated. So based on the initial vaccines given to health care workers and high risk elderly groups in December, that means the booster will be distributed in September. Pfizer submitted initial booster shot data to the FDA, which showed that when compared to 2 shots of the vaccine, their booster shot triggered a much higher antibody response against the initial strain of SARS-CoV-2, in addition to the Delta and Beta variants.
 

marsh

On TB every waking moment

Holy Shite — Blistering Covid speech in San Diego…
Posted by Kane on August 18, 2021 4:23 pm

View: https://twitter.com/i/status/1427849481551106056
2:11 min

A thing of beauty, just sit back and listen.

More from last night’s San Diego County supervisor’s meeting.
 

marsh

On TB every waking moment

The Conservative Alternative to the Drudge Report
mRNA Tech Inventor Dr. Robert Malone_ Easier for Delta to Kill 'Vaccinated' than Jab-Free People


mRNA Tech Inventor Dr. Robert Malone: Easier for Delta to Kill ‘Vaccinated’ than Jab-Free People

By J.D. Rucker • Aug. 18, 2021

Those who take the Covid-19 “vaccines” are MORE susceptible to the Delta Variant and have a HIGHER risk of severe disease or even death. This information comes from Dr. Robert Malone, the inventor of the very mRNA technology used to transmit both the Pfizer and Moderna injections.

Malone took to Twitter to post a thread that has shockingly not been taken down yet. Twitter has been censoring posts that speak ill of the “vaccines,” and a high-profile physician and researcher like Dr. Malone seems ripe for censorship. Perhaps they fear the “Streisand Effect” with this particular thread and are simply suppressing it on the back end.

Here is his thread edited for format:
I guess I need to say this again. Delta has an Ro of about 8, about 3x that of the Alpha (ref- CDC). With these leaky vaccines, if we were to have 100% vaccine uptake and perfect mask use we cannot stop the spread of Delta (ref- CDC).
  • the current vaccines provide about 50-60% efficacy in protection from infection. They are not fully protective.
  • if you are vaccinated and become infected (“breakthrough”), the virus will replicate at the same or higher levels than if you were unvaccinated and then become infected.
  • if you are vaccinated and then become infected, your risk of transmitting virus to someone else is quite high – remember, the Ro measures how likely you are to transmit the virus.
  • if you are vaccinated and then become infected, your risk of developing severe disease or dying is better than if you were not vaccinated and then become infected with Delta.
Therefore, if you are vaccinated and then become infected, you MAY have a higher risk of becoming a “superspreader” because you are less likely to show disease. This has not been measured, but it should be.
1629346720098.png

1629346764450.png

1629346828228.png

“Trust the science,” they say when scolding us about the “vaccines.” As the science increasingly points to these injections being dangerous, the tune is quickly shifting from the authoritarians. Now, they’re just saying to trust them. Which we don’t.
 
Last edited:

marsh

On TB every waking moment

ELDERLY PATIENT SAYS EMORY UNIVERSITY HOSPITAL MIDTOWN DENIED OUTPATIENT MEDICAL CARE OVER REFUSAL TO VAX/PCR TEST


August 17, 2021
e.jpg
Emory University Hospital – Midtown, Atlanta, GA
Image by Warren LeMay


The following is a statement we received today from the daughter of an elderly woman who has been a patient at Emory University Midtown Hospital for decades. We spoke to the mother also and verified her side of the story. We tried to contact Emory Hospital and are waiting on a response.

————————–
So mom is in her 70s, long time patient at Emory Midtown. Saw one of her docs there last week no problem. Called today to make an appointment with another of her doctors, a Specialist in the Medical Office Tower of Emory University Hospital Midtown. Phone screener said, I have a few questions for you. Mom said ok, shoot.

Are you vaccinated?

No. Why would you even ask that?

You either have to be vaccinated or take a COVID test when you get here.

What kind of covid test? One of those ones that goes all the way up to your brain?

Yes, a PCR test.

I had one of those before, because of all my breathing issues it caused me a lot of pain. I don’t consent to that test, which is my choice.

Well then you won’t be able to come see the doctor.

You can’t do that.

Well, that’s our policy Ma’am.

Whose policy? I want to talk to whoever made that policy.

Well Ma’am, you can’t come here if you aren’t vaccinated or have a PCR test when you get here. I’ll tell the doctor’s office you won’t do either and I’ll have them call you if they decide to change what I’ve told you. click

Mom has severe health issues and needs to see her doctor. They are willing to let her go untreated because she chooses not to get the jab or have a carcinogen soaked qtip stuck up to her brain. Which is exponentially more deadly than covid given her conditions.

They would rather she stay home and deteriorate after being a patient there for decades.

First do no harm, right????

Screen-Shot-2021-08-17-at-9.22.23-PM.png


Editor’s Note – we spoke with Emory Healthcare and were told it depends on the specialty as to whether or not vaccine/PCR Test is required.
 

Bogey

“Where liberty dwells, there is my country.”

Holy Shite — Blistering Covid speech in San Diego…
Posted by Kane on August 18, 2021 4:23 pm

View: https://twitter.com/i/status/1427849481551106056
2:11 min

A thing of beauty, just sit back and listen.

More from last night’s San Diego County supervisor’s meeting.

I watched a good portion of that meeting 2+ hours. I'm assuming the POS Fletcher is the County Mayor or of similar standing. One of the speakers took the effort to out his campaign contributions. The most damning Astra Zeneca!

Another person outed his membership in the World Economic Forum. Which was another mic drop moment.

Phrases like "We are coming for you" One young lady's comment "I'm fed up... no I'm fed the f@ck up" Another colorful moment "f@ck you! This is BS..." Lots of similar statements. The fire is growing! The "We Will Not Comply" movement is starting to take hold.

I believe, TPTB are beginning to lose the narrative war. Hang tough, the ride is about to get very interesting. The harder the pushback, the more desperate they will become. After one hundred years of chipping away at liberty, TPTB will not just take their ball and go home. They went all in hoping for a Full House, and ended up with a pair of deuces and trey's with a 5 high.

The sleeping giant is beginning to wake up. IMHO, mandates are the tipping point.
 
Last edited:

thompson

Certa Bonum Certamen

Holy Shite — Blistering Covid speech in San Diego…
Posted by Kane on August 18, 2021 4:23 pm

View: https://twitter.com/i/status/1427849481551106056
2:11 min

A thing of beauty, just sit back and listen.

More from last night’s San Diego County supervisor’s meeting.
Here is another very well-spoken RN at the same meeting...

View: https://twitter.com/Zieleds/status/1428003297776996356?s=20
 

33dInd

Veteran Member
So. My neighbor and friend was told by his doctor. Get the shot or don’t come back
Two weeks latter she (the doctor) retired and moved out of country

My police department I retired from. It’s a 40 man force. They are down 8 plus one dispatcher. One arrest. Drunk. Booked in. Held over night. Now they wear gloves and mask when in direct contact. One contact infected 9. Six had the jab prior and two had already had it once.

What’s the answer?????? Me thinks there isn’t one now
If masks don’t work
If the jab don’t work
If prior illness don’t give immunity

Then what?
 
Last edited:

ChicagoMan74

ULTRA MAGA
Huge study supporting ivermectin as Covid treatment withdrawn over ethical concerns | Medical research | The Guardian

Huge study supporting ivermectin as Covid treatment withdrawn over ethical concerns
This article is more than 1 month old
The preprint endorsing ivermectin as a coronavirus therapy has been widely cited, but independent researchers find glaring discrepancies in the data
Ivermectin

Ivermectin is a common drug used for treating parasites. A study saying it was an effective Covid treatment has now been retracted. Photograph: Soumyabrata Roy/NurPhoto/REX/Shutterstock

Melissa Davey
@MelissaLDavey
Thu 15 Jul 2021 13.30 EDT

The efficacy of a drug being promoted by rightwing figures worldwide for treating Covid-19 is in serious doubt after a major study suggesting the treatment is effective against the virus was withdrawn due to “ethical concerns”.
The preprint study on the efficacy and safety of ivermectin – a drug used against parasites such as worms and headlice – in treating Covid-19, led by Dr Ahmed Elgazzar from Benha University in Egypt, was published on the Research Square website in November.

It claimed to be a randomised control trial, a type of study crucial in medicine because it is considered to provide the most reliable evidence on the effectiveness of interventions due to the minimal risk of confounding factors influencing the results. Elgazzar is listed as chief editor of the Benha Medical Journal, and is an editorial board member.


The study found that patients with Covid-19 treated in hospital who “received ivermectin early reported substantial recovery” and that there was “a substantial improvement and reduction in mortality rate in ivermectin treated groups” by 90%.
But the drug’s promise as a treatment for the virus is in serious doubt after the Elgazzar study was pulled from the Research Square website on Thursday “due to ethical concerns”. Research Square did not outline what those concerns were.

A medical student in London, Jack Lawrence, was among the first to identify serious concerns about the paper, leading to the retraction. He first became aware of the Elgazzar preprint when it was assigned to him by one of his lecturers for an assignment that formed part of his master’s degree. He found the introduction section of the paper appeared to have been almost entirely plagiarised.

It appeared that the authors had run entire paragraphs from press releases and websites about ivermectin and Covid-19 through a thesaurus to change key words. “Humorously, this led to them changing ‘severe acute respiratory syndrome’ to ‘extreme intense respiratory syndrome’ on one occasion,” Lawrence said.
The data also looked suspicious to Lawrence, with the raw data apparently contradicting the study protocol on several occasions.
“The authors claimed to have done the study only on 18-80 year olds, but at least three patients in the dataset were under 18,” Lawrence said.
“The authors claimed they conducted the study between the 8th of June and 20th of September 2020, however most of the patients who died were admitted into hospital and died before the 8th of June according to the raw data. The data was also terribly formatted, and includes one patient who left hospital on the non-existent date of 31/06/2020.”

There were other concerns.

“In their paper, the authors claim that four out of 100 patients died in their standard treatment group for mild and moderate Covid-19,” Lawrence said. “According to the original data, the number was 0, the same as the ivermectin treatment group. In their ivermectin treatment group for severe Covid-19, the authors claim two patients died, but the number in their raw data is four.”
Lawrence and the Guardian sent Elgazzar a comprehensive list of questions about the data, but did not receive a reply. The university’s press office also did not respond.
Lawrence contacted an Australian chronic disease epidemiologist from the University of Wollongong, Gideon Meyerowitz-Katz, and a data analyst affiliated with Linnaeus University in Sweden who reviews scientific papers for errors, Nick Brown, for help analysing the data and study results more thoroughly.
Brown created a comprehensive document uncovering numerous data errors, discrepancies and concerns, which he provided to the Guardian. According to his findings the authors had clearly repeated data between patients.

“The main error is that at least 79 of the patient records are obvious clones of other records,” Brown told the Guardian. “It’s certainly the hardest to explain away as innocent error, especially since the clones aren’t even pure copies. There are signs that they have tried to change one or two fields to make them look more natural.”
Other studies on ivermectin are still under way. In the UK, the University of Oxford is testing whether giving people with Covid-19 ivermectin prevents them ending up in hospital.

The Elgazzar study was one of the the largest and most promising showing the drug may help Covid patients, and has often been cited by proponents of the drug as evidence of its effectiveness. This is despite a peer-reviewed paper published in the journal Clinical Infectious Diseases in June finding ivermectin is “not a viable option to treat COVID-19 patients”.

Meyerowitz-Katz told the Guardian that “this is one of the biggest ivermectin studies out there”, and it appeared to him the data was “just totally faked”. This was concerning because two meta-analyses of ivermectin for treating Covid-19 had included the Elgazzar study in the results. A meta-analysis is a statistical analysis that combines the results of multiple scientific studies to determine what the overall scientific literature has found about a treatment or intervention.

“Because the Elgazzar study is so large, and so massively positive – showing a 90% reduction in mortality – it hugely skews the evidence in favour of ivermectin,” Meyerowitz-Katz said.
“If you remove this one study from the scientific literature, suddenly there are very few positive randomised control trials of ivermectin for Covid-19. Indeed, if you get rid of just this research, most meta-analyses that have found positive results would have their conclusions entirely reversed.”
Kyle Sheldrick, a Sydney doctor and researcher, also independently raised concerns about the paper. He found numbers the authors provided for several standard deviations – a measure of variation in a group of data points – mentioned in tables in the paper were “mathematically impossible” given the range of numbers provided in the same table.

UK A&E department

Sheldrick said the completeness of data was further evidence suggesting possible fabrication, noting that in real-world conditions, this was almost impossible. He also identified the duplication of patient deaths and data.
Ivermectin has gained momentum throughout Latin America and India, largely based on evidence from preprint studies. In March, the World Health Organization warned against the use of ivermectin outside well designed clinical trials.
The conservative Australian MP Craig Kelly, who has also promoted the use of the anti-malarial drug hydroxychloroquine to treat Covid-19 – despite World Health Organization advice that clinical trials show it does not prevent illness or death from the virus – has been among those promoting ivermectin. Several Indian media outlets ran stories on Kelly in the past week after he asked Uttar Pradesh to loan the state’s chief minister, Adityanath, to Australia to release ivermectin. After this story was initially published, Kelly contacted the Guardian to say he disagreed that there was no evidence that hydroxychloroquine worked, and that he stood by his views.
Lawrence said what started out as a simple university assignment had led to a comprehensive investigation into an apparent scientific fraud at a time when “there is a whole ivermectin hype … dominated by a mix of right-wing figures, anti-vaxxers and outright conspiracists”.

“Although science trends towards self-correction, something is clearly broken in a system that can allow a study as full of problems as the Elgazzar paper to run unchallenged for seven months,” he said.
“Thousands of highly educated scientists, doctors, pharmacists, and at least four major medicines regulators missed a fraud so apparent that it might as well have come with a flashing neon sign. That this all happened amid an ongoing global health crisis of epic proportions is all the more terrifying.”
 

Bogey

“Where liberty dwells, there is my country.”
The pushback is growing. The drumbeats are getting louder.

'Don't be bullied': Billboard campaign exposes risks of COVID-19 vaccine - Alpha News (alphanewsmn.com)

Don’t be bullied’: Billboard campaign exposes risks of COVID-19 vaccine
"There is a media blackout on the adverse reactions," Twila Brase with the Citizens' Council for Health Freedom said.
By
Anna Miller
-
August 18, 2021
https://www.facebook.com/sharer.php...d-campaign-exposes-risks-of-covid-19-vaccine/

Twitter

A billboard in Elk River, Minnesota. (Photo courtesy of Citizens' Council for Health Freedom)

A new billboard campaign informs passersby of the risks associated with the COVID-19 vaccine and provides resources to learn more.

The billboards, which have gone up in Minnesota and Wisconsin, are funded by the Citizens’ Council for Health Freedom (CCHF), an organization that has been sharing information about adverse effects of the COVID vaccine, a topic that is not being covered by mainstream media.

“Don’t be bullied,” reads the billboard. “Make an informed choice!”
According to the group, there have been 571,830 reports of adverse events, which can include “everything from death to simply getting the wrong dose.”

Some of these reactions include cardiovascular issues, inflammation, and nervous system disorders. Also included on the list of reported reactions are adverse events during pregnancy, such as stillbirths and miscarriages.
Another concern the group raises is that many of the long-term effects are unknown because of the rapid time frame in which the vaccines were approved and administered. The COVID vaccine was approved under emergency use authorization, while clinical trials of vaccines are usually completed in six to seven years on average.

The billboard’s graphic states that, as of August 9, there have been 6,207 deaths reported after vaccination. Since the billboard went up, that number has increased to 6,789 deaths.

“There is a media blackout on the adverse reactions, and essentially a government ban on access to the safe, cheap, and effective medications (ivermectin and hydroxychloroquine) that would keep almost everyone out of the hospital and allow almost everyone to recover,” CCHF President Twila Brase, a registered nurse and public health nurse, told Alpha News.
“This is a dangerous situation. People are dying, or living in fear, unnecessarily,” Brase continued.
The council’s current objective not only includes educating the public on potential reactions to the vaccine but also providing resources on combating vaccine mandates. The group gives information and resources on the rights of employees to refuse vaccination, as well as other legal information.

A CDC report from Dr. Amanda Cohn says that “vaccines are not allowed to be mandatory” under emergency use authorization. Cohn, who is the executive secretary of the CDC’s Advisory Committee on Immunization Practices, said this applies to organizations and includes hospitals.
 
Top